individual probe results. Tables 2 and 3 show the results of standardized tests, and effect sizes for probes across all phases of the study.
Primary outcome measure: Noun and Verb Probes
As expected with this heterogenous group of participants, variable effect sizes were demonstrated across noun and verb probes. Of a total 44, 31 effect sizes reached small (2), medium (9), or large (20) levels. Overall, higher effect sizes were found for nouns and for items treated during the first treatment phase, irrespective of the treatment type.
Secondary outcome measure: Western Aphasia Battery Aphasia Quotient (WAB AQ)
All participants demonstrated improvement on the WAB AQ on at least one time point. A recent Rasch analysis has suggested variable standard error of measurement for WAB AQ according to aphasia severity ranging from <2 points (AQs 30-70) to >6 (AQ <20; AQ >90) (Hula et al., 2010) . In this study, we chose a somewhat conservative AQ change score of 3 points overall and/or a 1 point change on either the fluency or information rating score (Spontaneous Speech section) to reflect treatment responsiveness (see bold text Table 2 ). Using these criteria, all participants responded to the treatments.
A comparison of WAB AQ immediately following M-MAT as compared to immediately following CIATplus revealed four participants favored M-MAT (> 2 point WAB AQ difference between M-MAT and CIATplus) and five participants favored CIATplus. Order effects are likely to have played a significant role: seven participants achieved greater WAB AQ change scores following the first treatment than following the second treatment phase (compared to mid-phase scores).
Discussion
This well-controlled, phase one study directly compared M-MAT and CIATplus, two intensive but fundamentally different treatments with opposing rationales: constraint versus multi-modal support. Results suggest they are equally efficacious, though order effects may have masked clear differences. Discussion will center upon the participant variables associated with the best response to treatment, the need for large-scale randomized studies comparing these two treatments, and the likely mechanisms underpinning multi-modal treatment response in chronic aphasia. 
